Human CD5 signaling and constitutive phosphorylation of C-terminal serine residues by casein kinase II

Journal of Immunology

Volumn 161, Issue 11, 1998, Pages 6022-6029

  Calvo, Javier ^a   Vildà, Josep M ^a   Places, Lourdes ^a   Simarro, María ^a   Padilla, Olga ^a   Andreu, David ^b   Campbell, Kerry S ^c   Aussel, Claude ^d   Lozano, Francisco ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

^d CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN KINASE; CD5 ANTIGEN; GLYCOPROTEIN; PEPTIDE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIGEN SPECIFICITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; DNA SEQUENCE; ENZYME PHOSPHORYLATION; IMMUNOPRECIPITATION; ISOTOPE LABELING; LEUKEMIA CELL LINE; MAMMAL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; YEAST;

AMINO ACID SEQUENCE; ANTIGENS, CD5; BINDING SITES; CASEIN KINASE II; DIGLYCERIDES; HUMANS; JURKAT CELLS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; SERINE; SIGNAL TRANSDUCTION; SUBSTRATE SPECIFICITY;

EID: 0032402258     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Resnick, D., A. Pearson, and M. Krieger. 1994. The SRCR super-family: a family reminiscent of the Ig superfamily. Trends Biochem. Sci. 19:5.
2. Hardy, R. R., and K. Hayakawa. 1986. Development and physiology of Ly-1B and its human homolog, Leu-1. Immunol. Rev. 93:53.
3. Beyers, A. D., L. L. Spruyt, and A. F. Williams. 1992. Molecular associations between the T lymphocyte antigen receptor complex and the surface antigens CD2, CD4, or CD8 and CD5. Proc. Natl. Acad. Sci. USA 89:2945.
4. Lankester, A. C., G. M. W. van Schijndel, J. L. Cordell, C. J. M. van Noesel, and R. A. W. van Lier. 1994. CD5 is associated with the human B cell antigen receptor complex. Eur. J. Immunol. 24:812.
5. Tarakhovsky, A., S. B. Kanner, J. Hombach, J. A. Ledbetter, W. Müller, N. Killeen, and K. Rajewsky. 1995. A role for CD5 in TCR-mediated signal transduction and thymocyte selection. Science 269:535.
6. Bikah, G., J. Carey, J. R. Ciallella, A. Tarakhovsky, and S. Bondada. 1996. CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells. Science 274:1906.
7. Ledbetter, J. A., P. J. Martin, C. E. Spooner, D. Wofsy, T. T. Tsu, P. G. Beatty, and P. Gladstone. 1985. Antibodies to Tp67 and Tp44 augment and sustain proliferative responses of activated T cells. J. Immunol. 135:2331.
8. Ceuppens, J. L., and M. L. Baroja. 1986. Monoclonal antibodies to the CD5 antigen can provide the necessary second signal for activation of isolated resting T cells by solid-phase-bound OKT3. J. Immunol. 137:1816.
9. Alberola-Ila, J., L. Places, D. A. Cantrell, J. Vives, and F. Lozano. 1992. Intracellular events involved in CD5-induced human T cell activation and proliferation. J. Immunol. 148:1287.
10. Vandenberghe, P., and J. L. Ceuppens. 1991. Immobilized anti-CD5 together with prolonged activation of protein kinase C induce interleukin 2-dependent T cell growth: evidence for signal transduction through CD5. Eur. J. Immunol. 21:251.
11. Verwilghen, J., P. Vandenberghe, G. Wallays, M. de Boer, N. Anthony, G. S. Panayi, and J. L. Ceuppens. 1993. Simultaneous ligation of CD5 and CD28 on resting T lymphocytes induces T cell activation in the absence of T cell receptor/CD3 occupancy. J. Immunol. 150:835.
12. Simarro, M., C. Pelassy, J. Calvo, L. Places, C. Aussel, and F. Lozano. 1997. The cytoplasmic domain of CD5 mediates both TCR/CD3-dependent and -independent diacylglycerol production. J. Immunol. 159:4307.
13. lck. Cell 55:301.
14. Samelson, L. E., A. F. Phillips, E. T. Luong, and R .D. Klausner. 1990. Association of the fyn protein-tyrosine kinase with the T-cell antigen receptor. Proc. Natl. Acad. Sci. USA 87:4358.
15. lck: identification of a novel intermolecular association. Science 252:1523.
16. Irving, B. A., A. C. Chan, and A. Weiss. 1993. Functional characterization of a signal transducing motif present in the T cell antigen receptor ζ chain. J. Exp. Med. 177:1093.
17. Reth, M. 1989. Antigen receptor tail clue. Nature 338:383.
18. Davies, A. A., S. C. Ley, and M. J. Crumpton. 1992. CDS is phosphorylated on tyrosine after stimulation of the T-cell antigen receptor complex. Proc. Natl. Acad. Sci. USA 89:6368.
19. fyn. Proc. Natl. Acad. Sci. USA 89:9311.
20. + thymocytes. J. Immunol. 159:3739.
21. Griffith, L. C., H. Schulman, and M. Tagawa. 1989. In vivo and in vitro phosphorylation of murine lymphocyte differentiation antigen CD5. Biochem. Biophys. Res. Commun. 159:536.
22. Lozano, F., J. Alberola-Ila, L. Places, T. Gallart, and J. Vives. 1990. Phosphorylation-mediated changes in the electrophoretic mobility of CD5 molecules. Eur. J. Biochem. 193:469.
23. Alberola-Ila, J., L. Places, F. Lozano, and J. Vives. 1993. Association of an activation inducible serine kinase activity with CD5. J. Immunol. 151:4423.
24. Litchfield, D. W., A. Arendt, F. J. Lozeman, E. G. Krebs, P. A. Hargrave, and K. Palczewski. 1990. Synthetic phosphopeptides are substrates for casein kinase II. FEBS Lett. 261:117.
25. Pearson, R. B., and B. E. Kemp. 1991. Protein kinase phosphorylation site sequences and consensus specificity motifs: tabulations. Methods Enzymol. 200:62.
26. Lozano, F., J. Alberola-Ila, L. Places, T. Gallart, and J. Vives. 1990. Protein kinase C-dependent up-regulation of CD5 surface expression on normal and lymphoblastoid T cells. Immunology 70:434.
27. Fields, G. B., and R. L. Noble. 1990. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int. J. Pept. Protein Res. 35:161.
28. Albericio, F., N. Kneib-Cordonier, S. Biancalana, L. Gera, R. I. Masada, D. Hudson, and G. Barany. 1990. Preparation and application of the 5-(4-(9-fluorenylmethyl oxycarbonil) aminomethyl-3,5-dimethoxyphenoxy) valeric acid (PAL) handle for the solid-phase of C-terminal peptide amides under mild conditions. J. Org. Chem. 55:3730.
29. Chevray, P. M., and D. Nathans. 1992. Protein interaction cloning in yeast: identification of mammalian proteins that react with the leucine zipper of jun. Proc. Natl. Acad. Sci. USA 89:5789.
30. Feilotter, H. E., G. J. Hannon, C. J. Rudell, and D. Beach. 1994. Construction of an improved host strain for two hybrid screening. Nucleic Acids Res. 22:1502.
31. Gietz, D., A. St. Jean, R. A. Woods, and R. H. Schiestl. 1992. Improved method for high efficiency transformation of intact yeast cells. Nucleic Acids Res. 20: 1425.
32. Breeden, L., and K. Nasmyth. 1985. Regulation of the yeast HO gene. Cold Spring Harbor Symp. Quant. Biol. 50:643.
33. Aussel, C., C. Pelassy, and B. Rossi. 1990. Breakdown of a phosphatidylcholine pool arising from the metabolic conversion of phosphatidylethanolamine as a novel source of diacylglycerol in activated T cells. J. Lipid Mediat. 2:103.
34. Tuazon, P. T., and J. A. Traugh. 1991. Casein kinase I and II-multipotential serine protein kinases: structure, function and regulation. Adv. Second Messenger Phosphoprotein Res. 23:123.
35. Alexander, D. R., and D. A. Cantrell. 1989. Kinases and phosphatases in T-cell activation. Immunol. Today 10:200.
36. Huang, H. S., N. H. Jones, J. L. Strominger, and L. A. Herzenberg. 1987. Molecular cloning of Ly-1, a membrane glycoprotein of mouse T lymphocytes and a subset of B cells: molecular homology to its human counterpart Leu-1/T1 (CD5). Proc. Natl. Acad. Sci. USA 84:204.
37. 2+/calmodulin-dependent kinase II δ. Eur. J. Immunol. 28:2167.
38. Lüscher, B., E. Christenson, D. W. Lithcfield, E. G. Krebs, and R. N. Eisenman. 1990. Myb DNA binding inhibited by phosphorylation at a site deleted during oncogenic activation. Nature 344:517.
39. Jain, N., R. Mahendran, R. Philp, G. R. Guy, Y. H. Tan, and X. Cao. 1996. Casein kinase II associates with Egr-1 and acts as negative modulator of its DNA binding and transcription activities in NIH 3T3 cells. J. Biol. Chem. 271:13530.
40. Chu, Z., T. A. McKinsey, L. Liu, X. Qi, and D. W. Ballard. 1996. Basal phosphorylation of the PEST domain in the IκBβ regulates its functional interaction with the c-rel proto-oncogene product. Mol. Cell. Biol. 16:5974.
41. Armstrong, S. A., D. A. Barry, R. W. Leggett, and C. R. Mueller. 1997. Casein kinase II-mediated phosphorylation of the C terminus of Sp1 decreases its DNA binding activity. J. Biol. Chem. 272:13489.
42. Pedrotti, B., and K. Islam. 1996. Dephosphorylated but not phosphorylated microtubule associated protein MAP1B binds to microfilaments. FEBS Lett. 388: 131.
43. Karki, S., M. K. Tokito, and E. L. F. Holzbaur. 1997. Casein kinase II binds to and phosphorylates cytoplasmic dynein. J. Biol. Chem. 272:5887.
44. Stover, D. R., and K. A. Walsh. 1994. Protein-tyrosine phosphatase activity of CD45 is activated by sequential phosphorylation by two kinases. Mol. Cell. Biol. 14:5523.
45. Jones, B. G., L. Thomas, S. S. Molloy, C. D. Thulin, M. D. Fry, K. A. Walsh, and G. Thomas. 1995. Intracellular trafficking of furin is modulated by the phosphorylation state of a casein kinase II site in its cytoplasmic tail. EMBO J. 14:5869.
46. Appel, K., P. Wagner, B. Boldyreff, O. Issinger, and M. Montenarh. 1995. Mapping of the interaction sites of the growth suppressor protein p53 with the regulatory β-subunit of protein kinase CK2. Oncogene 11:1971.
47. Koskinen, R., T. W. F. Göbel, C. A. Tregaskes, J. R. Young, and O. Vainio. 1998. The structure of avian CD5 implies a conserved function. J. Immunol. 160:4943.
48. Ward, S. G., R. Parry, C. LeFeuvre, D. M. Sansom, J. Westwick, and A. I. Lazarovits. 1995. Antibody ligation of CD7 leads to association with phosphoinositide 3-kinase and phosphatidylinositol 3,4,5-triphosphate formation in T lymphocytes. Eur. J. Immunol. 25:502.
49. Dennehy, K. M., R. Broszeit, D. Garnett, G. A. Durrheim, L. L. Spruyt, and A. D. Beyers. 1997. Thymocyte activation induces the association of phosphatidylinositol 3-kinase and pp120 with CD5. Eur. J. Immunol. 27:679.